Skip to content

Efficacy Of Boswellia serrata Roxb. (Twak and Niryas) on Atyartava (Excessive Menstural Bleeding)

A COMPARATIVE STUDY OF SHALLAKI (BOSWELLIA SERRATA ROXB.) TWAK AND NIRYAS W.S.R. TO RAKTAPRADAR. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076921
Enrollment
30
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Pt. Khushilal Sharma Ayu. College Bhopal M.P.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between Menarche and Menopause 2. Excessive bleeding during menstruation (change of more than 3 soiled pads/day) 3. Passing of large clots. 4. Prolonged Menstrual bleeding (more than 7 days) 5. Excessive bleeding for more than 2 consecutive cycles 6. Intermenstrual Bleeding

Exclusion criteria

Exclusion criteria: 1. Intrauterine growth such as Myomas, endometrial polyp etc. 2. Cancer of cervix and or uterus. 3. Hb less than 6 gm %. 4. Any other systemic disorders likely to influence menstrual cycle. 5. Case undergoing treatment for any other serious illness. 6. Woman using an IUCD/ OCP/depot. 7. Venereal disease. 8. Systemic cause mentioned below will also be kept under exclusion criteria: Severe hypertension,Liver dysfunction,Congestive cardiac failure,Patient having bulky uterus, Patients having bleeding from sites other than uterus,Patients having coagulation disorder

Design outcomes

Secondary

MeasureTime frame
Investigation: Blood: Hb%, TLC, DLC, ESR, CT, BTTimepoint: 30 days

Primary

MeasureTime frame
Improvment in subjective parameter of menorrhagia as- 1. Bleeding amount in no. of pads 2. Duration of flow or menstrual period (In no. of days) 3. Interval of Menstruation (in no. of days) 4. Pallor (Panduta) (Hb %) 5. Pain (Pain in abdomen / backache) 6. Weakness (Daurabalya) 7. Burning Sensation (Daha) Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Pragya Mandloi

Pt. Khushilal Sharma Ayu. College Bhopal M.P.

Sharmavinod389@gmail.com9926379195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026